In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


This content is currently on FREE ACCESS, enjoy another 37 days of free consultation

 

The importance of echocardiographic pulmonary flow notch ratio in the assessment of patients with acute pulmonary embolism

Session Poster session 1

Speaker Katarzyna Kurnicka

Congress : EuroEcho 2019

  • Topic : imaging
  • Sub-topic : Doppler Echocardiography
  • Session type : Poster Session
  • FP Number : P304

Authors : K Kurnicka (Warsaw,PL), A Furdyna (Warsaw,PL), S Goliszek (Warsaw,PL), B Lichodziejewska (Warsaw,PL), M Ciurzynski (Warsaw,PL), O Dzikowska-Diduch (Warsaw,PL), M Kostrubiec (Warsaw,PL), P Palczewski (Warsaw,PL), P Pruszczyk (Warsaw,PL)

Authors:
K Kurnicka1 , A Furdyna1 , S Goliszek1 , B Lichodziejewska1 , M Ciurzynski1 , O Dzikowska-Diduch1 , M Kostrubiec1 , P Palczewski2 , P Pruszczyk1 , 1Dept of Internal Medicine and Cardiology, Medical University of Warsaw - Warsaw - Poland , 2Medical University of Warsaw, First Department of Radiology - Warsaw - Poland ,

Citation:

Background: There are several echocardiographic features such as right ventricle dilatation, interventricular septum flattening, McConnel sign and 60/60 sign reflecting the extent and severity of acute pulmonary embolism (APE). In quite a large number of APE patients we can observe a pulmonary flow (PF) profile abnormality in the form of a mid-systolic notch (MSN).

Purpose: To assess the profile of pulmonary Doppler flow in consecutive patients with acute pulmonary embolism and to establish its clinical utility.

Methods:  We reviewed pulmonary Doppler flow profiles  from 127 consecutive patients (m. age 64 years,72 F) with symptomatic APE managed in our department. APE was confirmed by contrast-enhanced multi detector computed tomography when thromboemboli were visualized at least in segmental pulmonary arteries. Individuals with preexisting pulmonary arterial hypertension were excluded. The pulmonary flow notch ratio (PNR) defined as the time from onset of PF until mid-systolic notch divided by the time from notch to the end of pulmonary ejection was evaluated. The comparison of patients with PNR<1 (Group 1) and PNR > 1 (Group 2) was performed.

Results: We found the MSN in 50 patients (39.4%). Seventy seven patients had a normal shape of Doppler PF envelope. The presence of MSN was associated with more pronounced echocardiographic signs of right ventricle overload (RVOT diameter 32.4± 5.2 vs 29.1 ±3.3 mm, p<0.001;  TRPG 42.3 ± 14.4 vs 24.8 ±9.5 mmHg, p<0.0001; RVSP 49.4 ±14.9 vs 31.2 ±10.6 mmHg, p<0.0001; TAPSE 20.3± 4.1 vs 23.4 ±4.0 mm, p<0.001; PF Acceleration Time 64.5 ±13.7 vs 109.8 ±24.6 ms, p<0.001, and a presence of septal flattening). Obviously, patients with MSN presented more proximal location of thrombi in comparison to those with symmetrical shape of PF envelope (in MPA 18% vs 5.2%, p=0.038 and in both LPA+RPA 22% vs 9%, p=0.08, respectively). The PNR < 1 was found in 35 (70%) of 50 patients with MSN (Group 1). In these patients thrombi were located more proximally than in patients with PNR>1 (Group 2), and angio-CT confirm anatomically massive PE.  A percentage of patients with thrombi in both, left and right pulmonary arteries, in both lobar pulmonary arteries and lobar+ segmental arteries was higher in Group 1 (PNR<1) than in Group 2 (PNR>1): LPA+RPA: 28.6 vs 6.7%, lobar L and R: 57 vs 26.6%, lobar+segmental: 31 vs 20%. A number of patients with thrombi in the MPA was similar in both groups.

Conclusion: A noninvasive pulmonary flow notch ratio (PNR) may be useful for indicating APE patients with more extensive disease and proximal location of thrombi, at least in lobar pulmonary arteries.

This content is currently on FREE ACCESS, enjoy another 37 days of free consultation

 



Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are